收费全文 | 931773篇 |
免费 | 64076篇 |
国内免费 | 2373篇 |
耳鼻咽喉 | 12942篇 |
儿科学 | 30014篇 |
妇产科学 | 26694篇 |
基础医学 | 130807篇 |
口腔科学 | 25475篇 |
临床医学 | 76866篇 |
内科学 | 190869篇 |
皮肤病学 | 20124篇 |
神经病学 | 74143篇 |
特种医学 | 37131篇 |
外国民族医学 | 336篇 |
外科学 | 146410篇 |
综合类 | 19215篇 |
一般理论 | 262篇 |
预防医学 | 67495篇 |
眼科学 | 20999篇 |
药学 | 65760篇 |
中国医学 | 1963篇 |
肿瘤学 | 50717篇 |
2019年 | 7377篇 |
2018年 | 10631篇 |
2017年 | 8073篇 |
2016年 | 8432篇 |
2015年 | 9355篇 |
2014年 | 13096篇 |
2013年 | 20597篇 |
2012年 | 28177篇 |
2011年 | 30156篇 |
2010年 | 17877篇 |
2009年 | 16517篇 |
2008年 | 28338篇 |
2007年 | 30007篇 |
2006年 | 29938篇 |
2005年 | 29485篇 |
2004年 | 28185篇 |
2003年 | 27262篇 |
2002年 | 26695篇 |
2001年 | 42273篇 |
2000年 | 43748篇 |
1999年 | 36878篇 |
1998年 | 10123篇 |
1997年 | 9240篇 |
1996年 | 9173篇 |
1995年 | 8515篇 |
1994年 | 8136篇 |
1993年 | 7643篇 |
1992年 | 28250篇 |
1991年 | 27020篇 |
1990年 | 26439篇 |
1989年 | 25375篇 |
1988年 | 23602篇 |
1987年 | 23194篇 |
1986年 | 22274篇 |
1985年 | 21185篇 |
1984年 | 15842篇 |
1983年 | 13510篇 |
1982年 | 8113篇 |
1979年 | 14597篇 |
1978年 | 10227篇 |
1977年 | 8640篇 |
1976年 | 8160篇 |
1975年 | 8972篇 |
1974年 | 10702篇 |
1973年 | 10193篇 |
1972年 | 9664篇 |
1971年 | 8923篇 |
1970年 | 8585篇 |
1969年 | 8029篇 |
1968年 | 7687篇 |
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献Methods: A retrospective analysis was performed to identify patients with isolated PCL injuries that underwent reconstruction between 2001 and 2014. Patients with multi-ligamentous injury or another concomitant knee pathology were excluded. Medical records were reviewed for demographic, clinical and operative data. Patients were contacted for administration of a telephone-based questionnaire which included the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation form, Lysholm-Tegner scales, Marx activity scale (MAS), return to sport status, and patient satisfaction instruments.
Results: A total of 15 isolated PCL reconstructions in 14 patients with a mean age of 27.5 years (range 17–43) met the study inclusion criteria; mean follow up was 6.3 years (range 1.4–15.2). Pre-operatively, the primary complaint was knee instability in all patients; on physical examination, lack of a firm end point during posterior drawer testing was found in 93% (14/15) of the knees. In total, 12 of 15 knees underwent transtibial, single-bundle PCLR and three of 15 underwent tibial inlay, double bundle PCLR. Graft types included: quadriceps autograft (7/15), Achilles allograft (6/15), and hamstring autograft (2/15). There were no graft failures in our patient cohort. At most recent follow up the mean scores respectively on the IKDC form, Lysholm-Tegner scales and MAS were (standard deviation): 77.3 (16.5), 83.1 (17.9), 6.13 (2.6), and 7.1 (6.0). All fourteen patients were athletes prior to their injury and 79% (11/14) returned to sport and overall patient satisfaction was 9.2/10.
Conclusions: Isolated PCLR provides good outcomes at mean medium-term follow up with restoration of function, high rate of return to sport and overall patient satisfaction. 相似文献